title: Phase I study of NK012, a novel SN-38-incorporating micellar nanoparticle, in adult patients with solid tumors.
authors.affiliation: Division of Gastrointestinal Oncology, National Cancer Center Hospital, Pharmaceutical Research Laboratories and Pharmaceutical Development, Nippon Kayaku Co Ltd, Tokyo, Japan. thamaguc@ncc.go.jp
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Hamaguchi
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Doi
authors.forename: Takako
authors.initials: T
authors.lastname: Eguchi-Nakajima
authors.forename: Ken
authors.initials: K
authors.lastname: Kato
authors.forename: Yasuhide
authors.initials: Y
authors.lastname: Yamada
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Shimada
authors.forename: Nozomu
authors.initials: N
authors.lastname: Fuse
authors.forename: Atsushi
authors.initials: A
authors.lastname: Ohtsu
authors.forename: Shin-ichi
authors.initials: S
authors.lastname: Matsumoto
authors.forename: Masaya
authors.initials: M
authors.lastname: Takanashi
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Matsumura